Envarsus XR

How hard is it to find Envarsus XR in stock?

Envarsus XR scores a 60 out of 100 on our findability scale. As a single-source brand-name product manufactured exclusively by Veloxis Pharmaceuticals, it has no generic equivalent and is more vulnerable to supply disruptions than widely available generics. While it is not currently listed on the FDA Drug Shortage database as of February 2026, transplant patients have reported intermittent difficulty locating it at retail pharmacies due to its specialty status. Most pharmacies do not stock it routinely and may need to special-order it. Specialty pharmacies affiliated with transplant centers are typically the most reliable source.

Who Can Prescribe Envarsus XR?

Envarsus XR is prescribed almost exclusively by transplant specialists, including:

• Transplant nephrologists — kidney specialists who manage post-transplant immunosuppression
• Transplant surgeons — surgeons who perform kidney transplants and initiate immunosuppressive therapy
• Nephrologists — general kidney specialists who may co-manage transplant patients

Due to the critical nature of transplant immunosuppression and the need for regular blood-level monitoring, this medication is not typically prescribed by primary care physicians.

Is Envarsus XR a controlled substance?

No, Envarsus XR is not a controlled substance. It does not have a DEA schedule and is not subject to the prescribing restrictions that apply to controlled medications. However, it does carry an FDA boxed warning about increased risk of serious infections and malignancies, and it requires careful therapeutic drug monitoring through regular blood tests.

Common Side Effects of Envarsus XR

• Diarrhea
• Anemia
• Urinary tract infection
• Hypertension (high blood pressure)
• Tremor
• Constipation
• New onset diabetes mellitus
• Peripheral edema (swelling)
• Hyperkalemia (elevated potassium)
• Headache
• Nausea
• Insomnia

Serious side effects include increased risk of infections, lymphoma and other cancers, kidney damage (nephrotoxicity), neurotoxicity, and QT prolongation. Contact your transplant team immediately if you experience fever, unusual bruising, confusion, vision changes, or signs of infection.

Final Thoughts on Envarsus XR

Envarsus XR is a critical medication for kidney transplant recipients, offering the convenience of once-daily dosing with more stable Tacrolimus blood levels compared to twice-daily formulations. As a single-source brand-name product with no generic equivalent, it can be expensive and occasionally difficult to locate at retail pharmacies. Transplant patients should work closely with their transplant center's specialty pharmacy and explore Veloxis's patient assistance programs if cost is a concern. Never switch between Tacrolimus formulations on your own — even small changes in blood levels can affect transplant outcomes. If you're having trouble finding Envarsus XR in stock, Medfinder can help you locate pharmacies with availability near you.